STE
STERIS plcPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Apr 30 to May 27 ▲ 5 buys: April McClain Delaney, Gilbert Cisneros and 1 more bought $1,001 - $15,000, last disclosed Jun 11
- Jun 2 to Jun 5 ▼ 3 days of insider sells: $1.3M by 2 insiders, avg $212.74
- Jun 15 ▼ 1 insider sell $297.0K at $209.28
- Jun 30 ▲ 5 funds open new positions (13F)
- Jul 13 to Jul 31 ▼ 5 sells: Jared Moskowitz, April McClain Delaney sold $1,001 - $15,000, last disclosed Aug 28
- Aug 12 ▼ 1 insider sell $956.8K at $235.78
- Aug 14 ▲ Short interest falls 26.7% to 2.32M
- Sep 25 to Oct 7 ▼ 2 sells: Ro Khanna sold $1,001 - $15,000, last disclosed Nov 9
- Oct 28 Dividend: STERIS Announces Dividend of $0.69 per share
- Nov 4 ▲ STERIS reported fiscal Q2 2027 results with revenue of $1.59B (+9% Y…
- Nov 10 to Nov 11 ▼ 2 days of insider sells: $2.7M by 2 insiders, avg $254.53
- Nov 13 ▲ Jefferies upgrades
Signal stack
Where each data set points today.
- InsidersBEARISH
5 insiders sold $5.3M.
- InstitutionsBULLISH
Q2 2026: 54 added (5 new), 30 trimmed or exited. Largest new: Worldquant Millennium Advisors $78.5M, Qube Research & Technologies $39.6M.
- AnalystsBULLISH
9 of 13 rate it Buy or better. Median target $285.00 (+9%).
- Short sellersSTEADY
Short interest −9.0% to 2.18M shares. 2.9 days to cover, ≈2.3% of shares.
- TrendUPTREND
17% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| Boston Partners | ADD | $315.5M |
| GOLDMAN SACHS GROUP INC | DOUBLED | $287.0M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | $256.4M |
| RAYMOND JAMES FINANCIAL INC | TRIM | $127.0M |
| Amundi | TRIM | $108.1M |
| D. E. Shaw & Co., Inc. | DOUBLED | $107.3M |
| CITADEL ADVISORS LLC | DOUBLED | $85.1M |
| UBS Group AG | TRIM | $83.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
13 analystsPrice is inside the target range. Median implies +9%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 13, 2026 | Jefferies UPGRADE | Buy |
| Nov 6, 2026 | Keybanc MAINTAIN | Overweight |
| Aug 7, 2026 | UBS MAINTAIN | Buy |
| Aug 7, 2026 | Piper Sandler REITERATE | Overweight |
| Jul 28, 2026 | UBS INITIATE | Buy |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Burton Karen L Sr. Vice Pres., CFO Nov 11, 2026 | EXERCISE | $864.7K |
Burton Karen L Sr. Vice Pres., CFO Nov 11, 2026 | SELL | $1.5M |
Sohi Mohsen Director Nov 10, 2026 | SELL | $422.7K |
Sohi Mohsen Director Nov 10, 2026 | EXERCISE | $561.4K |
Sohi Mohsen Director Nov 10, 2026 | SELL | $816.3K |
Burton Karen L Sr. Vice Pres., CFO Oct 1, 2026 | TAX W/H | 228 sh |
Sohi Mohsen Director Aug 12, 2026 | EXERCISE | $349.9K |
Sohi Mohsen Director Aug 12, 2026 | SELL | $956.8K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
20 filings · 1 press release · 3 bullish · 1 bearish · 1 mixed · 15 neutral- NEUTRAL 144Nov 13, 2026
Julia Madsen, an officer of STERIS plc, filed a Form 144 notice of intent to sell 2,046 ordinary…
This is a small, routine insider sale by an officer exercising and selling restricted stock. No material signal for the stock. Monitor for any larger insider sales or changes in insider trading…
- NEUTRAL CLUSTERNov 12, 2026
CFO Karen Burton and Director Mohsen Sohi sold a combined $1.93M in open-market sales within days…
The dollar value of insider sales is negligible for a company of STERIS's size. The CFO's sale is likely a routine portfolio rebalancing after derivative exercises. No bearish signal; monitor next…
- NEUTRAL 8-KNov 12, 2026
STERIS priced a $1.5 billion senior notes offering ($750M 5.650% notes due 2033 and $750M 5.875%…
Monitor the closing of the Xodus Medical acquisition and the associated increase in STERIS's leverage. The new $1.6B revamp of the revolving credit facility suggests ongoing liquidity management.
- NEUTRAL 144Nov 12, 2026
Karen L. Burton, an officer of STERIS plc, filed a Form 144 notice to sell 5,880 ordinary shares…
This is a routine insider sale tied to a cashless option exercise, not a discretionary market sale. No additional insider sales have been flagged in the filing. Monitor for any cluster of insider…
All STE filing & press-release reports (21)
- 144 reportNov 13, 2026
- CLUSTER reportNov 12, 2026
- 8-K reportNov 12, 2026
- 144 reportNov 12, 2026
- 144 reportNov 10, 2026
- 8-K reportNov 4, 2026
- 8-K reportNov 4, 2026
- PRESS-RELEASE reportNov 4, 2026
- PRESS-RELEASE reportOct 28, 2026
- PRESS-RELEASE reportOct 20, 2026
- 8-K reportOct 13, 2026
- PRESS-RELEASE reportJul 27, 2026
- 144 reportJun 15, 2026
- DEFA14A reportJun 11, 2026
- CLUSTER reportJun 8, 2026
- 144 reportJun 5, 2026
- 144 reportJun 4, 2026
- PRESS-RELEASE reportMay 11, 2026
- 8-K reportMay 11, 2026
- 8-K reportMay 7, 2026
- PRESS-RELEASE reportApr 21, 2026